Cynosure Acquires MyEllevate Surgical Suture System

April 30, 2021

Cynosure, a PE-backed medical aesthetics device company, has agreed to acquire the MyEllevate Surgical Suture System to expand its portfolio of minimally invasive facial rejuvenation solutions. The deal brings the patented ICLED light-guided suture technology and associated disposable surgical kit into Cynosure's product lineup to offer physicians a less-invasive alternative for facial/neck rejuvenation.

Buyers
Cynosure
Targets
MyEllevate
Sellers
Dr. Gregory Mueller
Platforms
Cynosure
Industry
Medical Devices
Location
California, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.